Brad Vale on the Evolution of an Innovative Industry
In his constant search for the latest trends in medtech investment, Brad Vale shares some secrets to the success of one of the oldest corporate venture arms. The Biodesign Alumni group recently had the...
View ArticleLife Science On The Rebound, But Device Is A Little Flat
Despite frequent grumblings heard throughout our industry, the data show that the Life Science investing climate might not be as bad as we were all led to believe. In the July Silicon Valley Bank...
View ArticleThe Modern-Day Physician-Innovator: Todd Alamin, MD
The medtech industry is built upon the ideas of creative physicians thinking outside the box; here’s advice from a modern-day physician-innovator. Given their understanding of disease and...
View ArticleThe Five Cardinal Sins of Pitching to Dr. Thomas Fogarty
When Dr. Thomas Fogarty is in the office, he holds meetings all day long. Not unlike the President, he is briefed moments before every meeting. With each new visitor, he brings a fresh enthusiasm to...
View ArticleA Dinner with Missy Krasner, EIR, Morgenthaler Ventures—What is up with VCs...
For our most recent Tableside Chat, we decided to invite a guest that is active in the area of healthcare IT (HIT) and digital health. Missy Krasner is currently looking for good opportunities for...
View ArticleThe Rise of CV Ingenuity: Breaking All the “Rules”
Trade-offs drive success, conviction drives success, and team drives success. Duke Rohlen closed our Biodesign Alumni Annual Event with this quip and it provides a great summary of the CV Ingenuity...
View ArticleThe Tarsus Medical Story
How Tarsus Went From Funding to Acquisition in 3 Years Last Fall, the Biodesign Fellow Alumni were joined by Nick Mourlas and Avi Roop to discuss the story of Tarsus Medical. This was an especially...
View ArticleA Success by Any Other Name…
What does success look like for medical devices these days? It’s easy to lose track of the wins with all the doom-and-gloom circulating about reimbursement struggles and regulatory pitfalls. Success...
View ArticleUlthera team shares key to success at this year’s SBAA annual alumni event
This year’s SBAA annual alumni event featured a presentation by Ulthera, the Mesa, Arizona-based aesthetic therapeutic company, along with a dynamic panel consisting of Matt Likens (Ulthera CEO),...
View ArticleAccessClosure – from extinction to distinction
On Monday, November 19th, Biodesign Alumni got to hear one of the most incredible turnaround stories in medtech history when Fred Khosravi, John Buckley, Greg Casciaro and Hank Plain shared the story...
View ArticleCan Y Combinator companies hack medtech?
Those of us who went through the Biodesign fellowship in recent years have heard many times how ridiculous it is to start a medical device company out of the program in the current environment. When my...
View ArticleiRhythm team shares success story at this year’s SBAA annual alumni event
This year’s Biodesign Alumni Annual Event featured a panel discussion with the iRhythm team. The San Francisco-based company has changed the way cardiac arrhythmias are diagnosed through their cloud...
View Article
More Pages to Explore .....